SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : JNJ-Super company, Super stock!
JNJ 187.12-0.9%9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: epicure who wrote (523)2/9/2006 4:28:21 AM
From: Lance Bredvold   of 552
 
And an apparent pullback in JNJ R&D spending from Tuck on the Biotech Valuation thread of SI.

From: tuck 2/8/2006 1:19:52 AM
of 18989

Somewhat OT as this is a pharma thang, but it looks as though J&J will be downsizing its pharma R&D operations, and hasn't yet said so:

pipeline.corante.com

Will it exit the biz, or has it figured the cash is better spent inlicensing biotech stuff? Who knows?

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News